Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Linbao Pharmaceutical is a comprehensive pharmaceutical manufacturer based in Harbin, China, specializing in the production of Traditional Chinese Medicine (TCM) and chemical drugs. Established in 1994, the company operates large-scale, GMP-certified facilities capable of producing various dosage forms, including sterile injections, tablets, and capsules. Its product portfolio is particularly strong in the cardiovascular and respiratory therapeutic areas, featuring well-known treatments such as Compound Salvia Miltiorrhiza and Qingkailing. The company serves the domestic Chinese market and focuses on integrating traditional herbal wisdom with modern pharmaceutical manufacturing standards. Linbao Pharmaceutical is recognized as a key industrial player in the Heilongjiang province healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Linbao Pharmaceutical.